Prescribing safely for children

Journal of Paediatrics and Child Health

Volumn 43, Issue 3, 2007, Pages 112-116

  Sinha, Yashwant ^a,b,d   Cranswick, Noel E ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Adverse drug reactions; Children; Medication error; Prescribing

Indexed keywords

ANILINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM CHLORIDE; CEFACLOR; CHLORAMPHENICOL; CODEINE; DIETHYLENE GLYCOL; DIGOXIN; FLUCLOXACILLIN; FUROSEMIDE; GENTAMICIN; GLUCONATE CALCIUM; HALOTHANE; HEPARIN; IBUPROFEN; INSULIN; LAMOTRIGINE; MORPHINE; NALOXONE; NARCOTIC AGENT; OPIATE; PARACETAMOL; POTASSIUM; POTASSIUM CHLORIDE; PROPOFOL; RANITIDINE; SALICYLIC ACID; SULFAFURAZOLE; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; ANAPHYLAXIS; CHILD; CHILD SAFETY; CLINICAL DECISION MAKING; DETOXIFICATION; DOSE CALCULATION; DRUG FORMULATION; DRUG INFUSION; DRUG LABELING; DRUG METABOLISM; DRUG PACKAGING; DRUG SAFETY; DRUG SYNTHESIS; FEVER; GASTROINTESTINAL HEMORRHAGE; GREY BABY SYNDROME; HEART ARRHYTHMIA; HEPATITIS; HUMAN; INFUSION RATE; KERNICTERUS; KIDNEY FAILURE; LIVER FAILURE; MEDICATION ERROR; METABOLIC ACIDOSIS; METHEMOGLOBINEMIA; PAIN; PHARMACIST; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; REYE SYNDROME; RISK REDUCTION; SEDATION; SERUM SICKNESS; SIDE EFFECT; SKIN MANIFESTATION; TACHYCARDIA; TOTAL PARENTERAL NUTRITION;

CHILD; CHILD, PRESCHOOL; HUMANS; PEDIATRICS; PHARMACOLOGY, CLINICAL; SAFETY;

EID: 33846797797     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.00971.x     Document Type: Review

References (38)

1. Marcovitch H. Safer prescribing for children. BMJ 2005; 331: 646-7.
2. Kaushal R, Bates D, Landrigan C et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114-20.
3. Selbst S, Levine S, Mull C, Bradford K, Friedman M. Preventing medical errors in pediatric emergency medicine. Pediatr. Emerg. Care 2004; 20: 702-9.
4. Chappell K, Newman C. Potential tenfold drug overdoses on a neonatal unit. Arch. Dis. Child. Fetal Neonatal Ed. 2004; 89: F483-F484.
5. Simpson J, Lynch R, Grant J, Alroomi L. Reducing medication errors in the neonatal intensive care unit. Arch. Dis. Child. Fetal Neonatal Ed. 2004; 89: F480-F482.
6. Fortescue E, Kaushal R, Landrigan C et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003; 111: 722-9.
7. Argo A, Cox K, Kelly W. The ten most common lethal medication errors in hospital patients. Hosp. Pharm. 2000; 35: 470-4.
8. National Patient Safety Agency.Patient Safety Alert. Potassium Chloride Concentrate Solutions. 23 July 2002. Available at: http://www.npsa.nhs.uk (accessed 24 May 2006).
9. Australian Council for Safety and Quality in Health Care. Medication Alert: Intravenous Potassium Chloride. Canberra: ACSQHC, 2003. Available at: http://www.safetyandquality.org/index.cfm?page=ACTION#potasalert (accessed 24 May 2006).
10. NSW Health Department. Circular 2004/5. Policy for the safe handling of intravenous potassium chloride in health care facilities. 2 February 2004.
11. Sinha Y, Dubury C, Grant P. Intravenous potassium chloride. Letter. Aust Pres 2005; 28: 85-6.
12. Kemp C, McDowell J. Paediatric Pharmacopoeia, 13th edn. Melbourne: Royal Children's Hospital, Women and Children's Health, 2002; 44-5.
13. Committee on drugs and committee on hospital care. Prevention of medication errors in the pediatric inpatient setting. American Academy of Pediatrics. Policy statement. Pediatrics 2003; 112: 431-6.
14. Gazarian M, Graudins LV. Safe prescribing in children: effective guidelines implementation can make a difference to patient safety. Abstract. Royal Australasian College Physicians Annual Scientific Meeting, May 2005. J. Paediatrics Child Health 2005; 41 (Suppl.): S1-S2.
15. WHO Collaborating Centre for International Drug Monitoring. Definitions. Available at: http://www.who-umc.org/ (accessed 24 May 2006).
16. Begg E. Instant Clinical Pharmacology. Oxford: Blackwell Publishing, 2003; 42.
17. Choonara I, Rieder M. Drug toxicity and adverse drug reactions in children - a brief historical overview. Paediat. Perinat Drug Ther. 2002; 5: 12-8.
18. O'Brien KL, Selaniko JD, Hecdivert C et al. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 1998; 379: 1175-80.
19. The use of the WHO-UMC System for Standardised Case Causality Assessment. Available at: http://www.who-umc.org/ (accessed 24 May 2006).
20. Naranjo CA, Busto U, Sellers EM et al. A method for assessing the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981; 30: 239-45.
21. Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and simple algorithm for assessment of adverse drug events. Clin. Pharmacol. Ther. 1995; 58: 692-8.
22. Reporting to ADRAC. What to Report. Available at: http://www.tga.gov.au/adr/report.htm (accessed 22 August 2005).
23. Goldman R, Ko K, Linett L, Scolnik D. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann. Pharmacother 2004; 38: 146-50.
24. Perrott D, Piira T, Goodenough B, Champion D. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain and fever. Arch. Pediatr. Adolesc. Med. 2004; 158: 521-6.
25. Rivera-Penera T, Gugig R, Davis J et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to toxicity. J. Pediatr. 1997; 130: 300-4.
26. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatotoxicity after multiple doses in children. J. Pediatr. 1998; 132: 22-7.
27. Kearns G, Leeder J, Wasserman G. Acetaminophen overdose with therapeutic intent. J. Pediatr. 1998; 132: 5-8.
28. Anderson BJ. What we don't know about paracetamol in children. Paediatr. Anaesth. 1998; 5: 451-8.
29. Lesko S, Mitchell A. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomised clinical trial. JAMA 1995; 273: 929-33.
30. Titchen T, Cranswick NE, Beggs S. Adverse drug reactions to nonsteroidal amt-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br. J. Clin. Pharmacol. 2005; 59: 718-23.
31. Carson S. Alternating acetaminophen and ibuprofen in the febrile child. examination of the evidence regarding efficacy and safety. Pediatr. Nurs. 2003; 29: 379-82.
32. Erlewyn-Lajeunesse MDS, Koppens K, Hunt LP et al. Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch. Dis. Child. 2006; 91: 414-6.
33. Sarrell EM, Wielunsky E, Cohen HA. Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Arch. Pediatr. Adolesc. Med. 2006; 160: 197-202.
34. Lesko S, O'Brien K, Schwartz B, Vezina R, Mitchell A. Invasive Group A Streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108-15.
35. Purssell E. Fever phobia revisited. Letter. Arch. Dis. Child. 2004; 89: 89-95.
36. Hale T. Medicines and Mother's Milk, 12th edn. Amarilo, Texas: Hale Publishing L.P., 2006.
37. Brigges G, Freeman R, Yaffe S. Drugs in Pregnancy and Lactation, 7th edn. Philadelphia: Pennsylvania: Lippincott Williams & Wilkins, 2005.
38. American Academy of Pediatrics. Committee on drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-89.